Some of these medications include: Selective serotonin reuptake inhibitors (SSRIs) such as Zoloft (sertraline), Paxil (paroxetine), Prozac (fluoxetine), and Celexa (citalopram) Serotonin and norepinephrine reuptake inhibitors (SNRIs) such as Effexor XR (venlafaxine) Antipsychotics such as Haldol (haloperidol) and Thorazine (thioridazine) Beta-blockers such as Lopressor (metoprolol) Antiarrhythmics such as Tambocor (flecainide) Monoamine oxidase inhibitors (MAOIs) Using an MAOI along with bupropion XL can raise your risk of having dangerously high blood pressure and even send you into a life-threatening hypertensive crisis
The active ingredients in these medications travel through your bloodstream to reach different parts of your body
For people with demanding schedules or limited access to specialists, this convenience is meaningful
By increasing GLP-1 production or stimulating its release, this approach can complement existing therapies, such as GLP-1RAs and DPP-4 inhibitors, offering additional benefits while potentially reducing side effects
Abstract Introduction Within the cardiovascular-kidney-metabolic syndrome (CKM) framework, semaglutide has demonstrated benefits beyond glycemic control and weight loss in clinical trials
